The Combination of T Stage and the Number of Pathologic Lymph Nodes Provides Better Prognostic Discrimination in Early-Stage Cervical Cancer With Lymph Node Involvement

ObjectiveStage I and II cervical cancer with pelvic and/or para-aortic lymph node (LN) metastases are upstaged to stage IIIC under the new FIGO 2018 staging system, and radical chemoradiotherapy was recommended. But heterogeneity in outcome existed in this group of patients. We conducted this retros...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yongrui Bai, Ling Rong, Bin Hu, Xiumei Ma, Jiahui Wang, Haiyan Chen
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/46afe542d43046d1ba6808b06d9a7eac
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:46afe542d43046d1ba6808b06d9a7eac
record_format dspace
spelling oai:doaj.org-article:46afe542d43046d1ba6808b06d9a7eac2021-11-05T12:41:13ZThe Combination of T Stage and the Number of Pathologic Lymph Nodes Provides Better Prognostic Discrimination in Early-Stage Cervical Cancer With Lymph Node Involvement2234-943X10.3389/fonc.2021.764065https://doaj.org/article/46afe542d43046d1ba6808b06d9a7eac2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.764065/fullhttps://doaj.org/toc/2234-943XObjectiveStage I and II cervical cancer with pelvic and/or para-aortic lymph node (LN) metastases are upstaged to stage IIIC under the new FIGO 2018 staging system, and radical chemoradiotherapy was recommended. But heterogeneity in outcome existed in this group of patients. We conducted this retrospective analysis to evaluate the heterogeneity of these patients and tried to provide a more detailed classification to reflect the prognosis and guide the treatment. We also evaluated the efficacy and toxicity of surgery followed by sequential chemoradiotherapy in this cohort.MethodsEarly-stage cervical cancer with LN involvement that had radical hysterectomy followed by sequential chemoradiotherapy were retrospectively analyzed. Survival analyses were conducted to identify the prognostic factors.ResultsA total of 242 patients were included in the study; 64 (26.4%) patients had treatment failure, and 51 (21.1%) died. Pathology, T stage, the number of pathologic LN (pLN), and neoadjuvant chemotherapy or not were independent prognostic factors for disease-free survival and overall survival (OS). Patients with T1N < 3 pLN had significantly better survival than T2N < 3 pLN/T1-2 N≥ 3 pLN, with failure rates of 11.6% and 35.8% in each group; and 5 year OS was 92% and 62%, respectively (P = 0.000). About 1.5% of the patients discontinued radiotherapy, and 14.1% had G3-4 hematological toxic effects during radiotherapy; 1.7% developed G2-3 lower limb edema, and 2.9% developed severe urinary toxicity.ConclusionNodal involvement alone is inadequate as the sole pathologic factor to predict survival in early-stage cervical cancer. The combination of tumor and node subcategory provides better prognostic discrimination.Yongrui BaiLing RongBin HuXiumei MaJiahui WangHaiyan ChenFrontiers Media S.A.articlecervical cancerlymph nodesequential chemoradiotherapyT stageN stageradical hysterectomyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic cervical cancer
lymph node
sequential chemoradiotherapy
T stage
N stage
radical hysterectomy
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle cervical cancer
lymph node
sequential chemoradiotherapy
T stage
N stage
radical hysterectomy
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Yongrui Bai
Ling Rong
Bin Hu
Xiumei Ma
Jiahui Wang
Haiyan Chen
The Combination of T Stage and the Number of Pathologic Lymph Nodes Provides Better Prognostic Discrimination in Early-Stage Cervical Cancer With Lymph Node Involvement
description ObjectiveStage I and II cervical cancer with pelvic and/or para-aortic lymph node (LN) metastases are upstaged to stage IIIC under the new FIGO 2018 staging system, and radical chemoradiotherapy was recommended. But heterogeneity in outcome existed in this group of patients. We conducted this retrospective analysis to evaluate the heterogeneity of these patients and tried to provide a more detailed classification to reflect the prognosis and guide the treatment. We also evaluated the efficacy and toxicity of surgery followed by sequential chemoradiotherapy in this cohort.MethodsEarly-stage cervical cancer with LN involvement that had radical hysterectomy followed by sequential chemoradiotherapy were retrospectively analyzed. Survival analyses were conducted to identify the prognostic factors.ResultsA total of 242 patients were included in the study; 64 (26.4%) patients had treatment failure, and 51 (21.1%) died. Pathology, T stage, the number of pathologic LN (pLN), and neoadjuvant chemotherapy or not were independent prognostic factors for disease-free survival and overall survival (OS). Patients with T1N < 3 pLN had significantly better survival than T2N < 3 pLN/T1-2 N≥ 3 pLN, with failure rates of 11.6% and 35.8% in each group; and 5 year OS was 92% and 62%, respectively (P = 0.000). About 1.5% of the patients discontinued radiotherapy, and 14.1% had G3-4 hematological toxic effects during radiotherapy; 1.7% developed G2-3 lower limb edema, and 2.9% developed severe urinary toxicity.ConclusionNodal involvement alone is inadequate as the sole pathologic factor to predict survival in early-stage cervical cancer. The combination of tumor and node subcategory provides better prognostic discrimination.
format article
author Yongrui Bai
Ling Rong
Bin Hu
Xiumei Ma
Jiahui Wang
Haiyan Chen
author_facet Yongrui Bai
Ling Rong
Bin Hu
Xiumei Ma
Jiahui Wang
Haiyan Chen
author_sort Yongrui Bai
title The Combination of T Stage and the Number of Pathologic Lymph Nodes Provides Better Prognostic Discrimination in Early-Stage Cervical Cancer With Lymph Node Involvement
title_short The Combination of T Stage and the Number of Pathologic Lymph Nodes Provides Better Prognostic Discrimination in Early-Stage Cervical Cancer With Lymph Node Involvement
title_full The Combination of T Stage and the Number of Pathologic Lymph Nodes Provides Better Prognostic Discrimination in Early-Stage Cervical Cancer With Lymph Node Involvement
title_fullStr The Combination of T Stage and the Number of Pathologic Lymph Nodes Provides Better Prognostic Discrimination in Early-Stage Cervical Cancer With Lymph Node Involvement
title_full_unstemmed The Combination of T Stage and the Number of Pathologic Lymph Nodes Provides Better Prognostic Discrimination in Early-Stage Cervical Cancer With Lymph Node Involvement
title_sort combination of t stage and the number of pathologic lymph nodes provides better prognostic discrimination in early-stage cervical cancer with lymph node involvement
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/46afe542d43046d1ba6808b06d9a7eac
work_keys_str_mv AT yongruibai thecombinationoftstageandthenumberofpathologiclymphnodesprovidesbetterprognosticdiscriminationinearlystagecervicalcancerwithlymphnodeinvolvement
AT lingrong thecombinationoftstageandthenumberofpathologiclymphnodesprovidesbetterprognosticdiscriminationinearlystagecervicalcancerwithlymphnodeinvolvement
AT binhu thecombinationoftstageandthenumberofpathologiclymphnodesprovidesbetterprognosticdiscriminationinearlystagecervicalcancerwithlymphnodeinvolvement
AT xiumeima thecombinationoftstageandthenumberofpathologiclymphnodesprovidesbetterprognosticdiscriminationinearlystagecervicalcancerwithlymphnodeinvolvement
AT jiahuiwang thecombinationoftstageandthenumberofpathologiclymphnodesprovidesbetterprognosticdiscriminationinearlystagecervicalcancerwithlymphnodeinvolvement
AT haiyanchen thecombinationoftstageandthenumberofpathologiclymphnodesprovidesbetterprognosticdiscriminationinearlystagecervicalcancerwithlymphnodeinvolvement
AT yongruibai combinationoftstageandthenumberofpathologiclymphnodesprovidesbetterprognosticdiscriminationinearlystagecervicalcancerwithlymphnodeinvolvement
AT lingrong combinationoftstageandthenumberofpathologiclymphnodesprovidesbetterprognosticdiscriminationinearlystagecervicalcancerwithlymphnodeinvolvement
AT binhu combinationoftstageandthenumberofpathologiclymphnodesprovidesbetterprognosticdiscriminationinearlystagecervicalcancerwithlymphnodeinvolvement
AT xiumeima combinationoftstageandthenumberofpathologiclymphnodesprovidesbetterprognosticdiscriminationinearlystagecervicalcancerwithlymphnodeinvolvement
AT jiahuiwang combinationoftstageandthenumberofpathologiclymphnodesprovidesbetterprognosticdiscriminationinearlystagecervicalcancerwithlymphnodeinvolvement
AT haiyanchen combinationoftstageandthenumberofpathologiclymphnodesprovidesbetterprognosticdiscriminationinearlystagecervicalcancerwithlymphnodeinvolvement
_version_ 1718444285248929792